SHOX2 and head and neck squamous cell carcinoma: Gene methylations of SEPT9 and SHOX2 were identified in patients with different types of HNSCC, regardless of tumor stage, and hypermethylation could be used as a valuable biomarker for diagnosis and prognosis.